Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy (Q36492134)

14 August 2017

1 reference

title

Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy (English)

1 reference

14 August 2017

Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy (English)

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

hypertrophic cardiomyopathy

25 October 2022

main subject

1 reference

Cardiology and cardiovascular medicine

inferred from title

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

25 October 2022

author name string

Ross J Jr

2

1 reference

14 August 2017

D. G. Blanchard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673364

25 October 2022

J. Ross

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673364

25 October 2022

language of work or name

1 reference

1 January 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fclc.4960140105

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

https://onlinelibrary.wiley.com/doi/full/10.1002/clc.4960140105

25 October 2022

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

25 October 2022

1 reference

14 August 2017

14

1 reference

14 August 2017

1

1 reference

14 August 2017

11-19

1 reference

The clinical course in muscular subaortic stenosis. A retrospective and prospective study of 60 hemodynamically proved cases

14 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Effects of operation on left atrial size and the occurence of atrial fibrillation in patients with hypertrophic subaortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Relation between echocardiographically determined left atrial size and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Angina in idiopathic hypertrophic subaortic stenosis. A clinical correlate of regional left ventricular dysfunction: a videometric and echocardiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Hypertrophic cardiomyopathy in infants: clinical features and natural history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Surgical relief of diffuse subvalvular aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

The natural history of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Sudden death in young athletes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Arrhythmias in Dilated and Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Hypertrophic cardiomyopathy and sudden death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Syncope in hypertrophic obstructive cardiomyopathy due to asystole

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Hypertrophic cardiomyopathy compatible with successful completion of the marathon

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force III: Hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Left ventricular cineangiographic observations in muscular subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Mitral regurgitation in idiopathic hypertrophic subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Mitral regurgitation in muscular subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Myocardial thallium 201 imaging in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Asymetric septal hypertrophy in childhood

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Long-term propranolol therapy in muscular subaortic stenosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Long-term medical management of hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Reappraisal of the effect of acute betablockade on left ventricular filling dynamics in hypertrophic obstructive cardiomyopathy*

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Treatment of hypertrophic obstructive cardiomyopathy with verapamil

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

https://api.crossref.org/works/10.1002%2FCLC.4960140105

1 reference

7 January 2021

Hemodynamic effects of intravenous amiodarone.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Amiodarone for long-term management of patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Effects of long-term treatment with amiodarone on exercise hemodynamics and left ventricular relaxation in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

TRANSATRIAL EXPOSURE FOR CORRECTION OF SUBAORTIC STENOSIS

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Diffuse muscular subaortic stenosis: Surgical treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Current operative treatment of obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Idiopathic hypertrophic subaortic stenosis. Long-term surgical follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Results of operation for obstructive hypertrophic cardiomyopathy in the elderly. Septal myotomy and myectomy in 20 patients 65 years of age or older

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

Operation for hypertrophic subaortic stenosis in the aged

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960140105

7 January 2021

The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy

8

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy

25 October 2022

58

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study

25 October 2022

70

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

THE SURGICAL MANAGEMENT OF OBSTRUCTIVE CARDIOMYOPATHY

25 October 2022

90

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

Techniques and complications of transaortic subvalvular myectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM)

25 October 2022

100

1 reference

https://api.crossref.org/works/10.1002/CLC.4960140105

25 October 2022

Identifiers

1 reference

14 August 2017

1 reference